Belite Bio (BLTE) Reports In-Line Q4 EPS

Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32).

For earnings history and earnings-related data on Belite Bio (BLTE) click here.

You May Also Be Interested In

• Belite Bio, Inc, ADR (BLTE) PT Raised to $214 at H.C. Wainwright
• Grok Bot launches in early beta for select subscribers
• Goldman Sachs expects July core PCE to rise 0.23%